Upper respiratory tract CD8+ tissue-resident memory T cells protect against viral transmission
Authors:
- Sarah E. MichaletsSMSarah E. Michalets
- Yixel Soto-VazquezYSYixel Soto-Vazquez
- Kathryn M. MooreKMKathryn M. Moore
- M. Elliott WilliamsMWM. Elliott Williams
- Ananya SahaASAnanya Saha
- Ariana JimenezAJAriana Jimenez
- Yu-Shan HuangYHYu-Shan Huang
- Anice C. LowenALAnice C. Lowen
- Christopher D. ScharerCSChristopher D. Scharer
- Alison Swaims-KohlmeierASAlison Swaims-Kohlmeier
- Rustom AntiaRARustom Antia
- Jacob E. KohlmeierJKJacob E. Kohlmeier
Open Access
- 10 September 2026
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (11)
Abstract
Intranasal vaccination elicits CD8 tissue-resident memory T cells (TRM) throughout the respiratory tract that provide cross-protection against heterosubtypic viral strains and reduce immunopathology. We previously demonstrated that CD8 TRM can reduce the probability of respiratory virus transmission and the magnitude of infection, using a murine model of parainfluenza virus transmission. Here, we show that CD8 TRM-mediated protection occurs independently of circulating leukocytes, B cells, or CD4 T cells. Additionally, we investigate the contributions of CD8 TRM in different respiratory tract compartments and illustrate that CD8 TRM in the upper respiratory tract (URT), but not the lower respiratory tract (LRT), become activated and proliferate in response to transmitted virus. Furthermore, we demonstrate that CD8 TRM in the URT alone provide sufficient immune surveillance to prevent propagation of infection after viral transmission. These findings offer insights into the development of T cell–based respiratory virus vaccines and shed light on the critical role of URT CD8 TRM in the prevention of viral transmission.Keywords
Funding Information
- National Institutes of Health (P51OD011132)
- National Institutes of Health (S10OD026799)
- National Institutes of Health (R35 HL150803)
- National Institutes of Health (R01 AI190367)
- National Institutes of Health (F31 HL168914)
This publication has 59 references indexed in Scilit:
- Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into airCell, 2026
- Human lung CD8+ tissue-resident memory T cell-derived interferon-γ orchestrates subset-specific antiviral programming in airway epithelial cellsImmunity, 2025
- Dynamics of virus-specific CD8+ T cells in the human nasal cavityMucosal Immunology, 2025
- Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variantsCell Reports, 2023
- Mucosal plasma cells are required to protect the upper airway and brain from infectionImmunity, 2022
- Mucosal immune responses to infection and vaccination in the respiratory tractImmunity, 2022
- Human influenza virus challenge identifies cellular correlates of protection for oral vaccinationCell Host & Microbe, 2021
- A Distinct Lung-Interstitium-Resident Memory CD8+ T Cell Subset Confers Enhanced Protection to Lower Respiratory Tract InfectionCell Reports, 2016
- Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cellsVaccine, 2015
- The role of particle size in aerosolised pathogen transmission: A reviewJournal of Infection, 2011